TY  - CHAP
M1  - Book, Section
TI  - Chapter 18. Solid Organ Transplantation
A1  - Park, Jeong M.
A1  - Jorgenson, Margaret R.
A2  - Sutton, S. Scott
PY  - 2011
T2  - McGraw-Hill's NAPLEX® Review Guide
AB  - Solid  organ  transplantation  has  been  accepted  as  a  lifesaving  treatment  for  patients  with  end-stage  kidney,  liver,  heart,  lung,  and  intestinal  disease.  The  benefit  of  pancreas  or  islet  cell  transplant  for  type  1  diabetic  patients  is  generally  not  immediate,  however  normoglycemia  without  the  need  for  exogenous  insulin  following  transplantation  offers  better  quality  of  life  and  potentially  reduces  long-term  diabetic  complications.1,2  In  2007,  27,578  transplants  were  performed  in  the  United  States.  Kidney  transplant  was  most  commonly  performed  followed  by  liver  and  heart.  However,  demand  far  surpasses  supply  with  about  100,000  people  on  the  waiting  list  to  receive  an  organ.3  
SN  - 
PB  - The McGraw-Hill Companies
CY  - New York, NY
Y2  - 2024/04/20
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=7251403
ER  -